Merck recently reaffirmed its commitment to enable broad equitable access to its human papillomavirus (HPV) vaccines.
Under the initiative, Merck will expand its vaccines manufacturing facility...
Moderna recently launched the Moderna Charitable Foundation to promote public health, access to quality healthcare, and educational opportunities, particularly in underserved populations.
The...
Thermo Fisher Scientific will invest $97 million to expand its clinical research operations in Virginia to support the increasing demand for drug development.
Over the next three years,...
Civica recently announced plans to manufacture and distribute insulin to diabetes patients at significantly lower prices than insulins currently on the market.
Civica, CivicaScript, and the...
Moderna and Thermo Fisher Scientific recently announced a 15-year collaboration agreement for dedicated large-scale manufacturing of Moderna’s COVID-19 vaccine and other mRNA vaccines in the...
Moderna recently expanded its mRNA pipeline with three new development programs, including an HSV mRNA vaccine, a varicella-zoster virus (VZV) vaccine, and a checkpoint cancer vaccine.
First, Moderna...
GSK and Sanofi recently announced that they will submit data from their Phase 3 efficacy and booster trials for regulatory approval of their COVID-19 vaccine.
The Phase 3 VAT08 efficacy study...
Pfizer and BioNTech recently initiated a rolling submission seeking to amend FDA’s emergency use authorization of their COVID-19 vaccine to include children six months to four years of age.
The...
FDA recently approved Takeda Pharmaceutical’sPharmaceutical’s Vonvendi for routine prophylaxis to reduce the frequency of bleeding episodes in patients with severe Type 3 von Willebrand...
FDA recently proposed a rule to provide greater assurance that supply chain participants are sufficiently qualified to distribute prescription drugs, strengthening the pharmaceutical supply chain.
The...
CVS Health and Medable recently collaborated to expand clinical trial access and engagement for patients at select MinuteClinic locations.
The collaboration will combine Medable’s software...
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recently issued a positive opinion of Pfizer’s COVID-19 treatment, Paxlovid.
The CHMP recommended...
FDA recently approved an update to the prescribing information for Kite’s Yescarta to include prophylactic corticosteroids across all approved indications.
The agency first approved Yescarta in...
Eli Lilly and Company recently announced plans to invest over $1 billion to create a new manufacturing site and boost access to medicine in Concord, North Carolina.
The facility will utilize the...
AstraZeneca recently announced that Imfinzi combined with standard-of-care chemotherapy significantly improved overall survival and progression-free survival in patients with advanced biliary tract...
Pfizer recently announced that its COVID-19 treatment, Paxlovid, maintained plasma concentrations many-fold times higher than the amount required to prevent the Omicron variant from replicating in...
FDA recently issued an emergency use authorization for Merck’s COVID-19 treatment, molnupiravir, for adults 18 years of age and older.
The agency authorized the treatment for adults with high...
GSK recently welcomed the decision of the Gavi Board to fund the procurement and introduction of malaria vaccines into routine child immunization programs in eligible countries.
GSK developed its...
GSK recently launched an international, multi-year initiative to advance innovation and address key needs in the multiple myeloma community.
The project, Target the Future, will provide education on...
AstraZeneca recently unveiled a $1 billion state-of-the-art research and development facility to advance next-generation therapeutics, including nucleotide-based gene-editing and cell therapies.
The...
